Dual-Action Recombinant Vesicular Stomatitis Virus (rVSV)-Based Vaccine Against COVID-19 and Influenza Viruses
A bivalent VSV vaccine against COVID-19 Delta Variant and Influenza Virus
Published: 31st May 2022

Patents
- US Provisional Application 63/236455
IP Status
- Patent application submitted
Seeking
- Development partner
- Commercial partner
- Licensing